ABSTRACT
INTRODUCTION
Cardiovascular disease is the main cause of mortality in developed countries, with research demonstrating a long subclinical phase that may last decades before clinical symptoms manifest 1, 2 . Large epidemiological studies associating low birth weight with myocardial infarction and cardiovascular-related events in adulthood were first reported almost three decades ago, introducing the concept of fetal programming of cardiovascular disease 3 . Recently, fetal cardiovascular adaptation to intrauterine growth restriction (IUGR) has been demonstrated to lead to primary cardiac changes, in the form of subclinical cardiovascular dysfunction and remodeling 4 -7 . The heart is a key organ in the process of fetal adaptation to hypoxia and undernutrition due to placental insufficiency in IUGR. Recent studies on fetal cardiac function have demonstrated that IUGR results in subclinical cardiovascular dysfunction in utero, which can be demonstrated by various echocardiographic parameters, such as pulsed/tissue Doppler imaging or M-mode 4,5,8 -10 . In addition, placental insufficiency has been associated with aortic restriction, higher resting heart rate, hypertension, increased vascular wall thickness and cardiac remodeling in newborns, infants, children and young adults that were growth-restricted in utero 6,11 -14 . However, the transition from fetal to postnatal cardiovascular remodeling has not been evaluated longitudinally. Consequently, the extent to which postnatal changes are a consequence of fetal cardiovascular remodeling or are influenced by other neonatal or early life events remains uncertain.
The aim of this study was to evaluate longitudinally the association between cardiovascular remodeling in small-for-gestational-age (SGA) fetuses and at 6 months of age.
METHODS

Study population
This was a prospective cohort study including cases with SGA and controls identified prenatally and followed into infancy. The source population comprised all pregnancies beyond 34 weeks' gestation between April 2010 and September 2012 seen at Hospital Clínic, Barcelona, Spain. Pregnancies with structural/chromosomal anomalies, twins or evidence of fetal infection or that had been conceived by assisted reproduction technologies were excluded from the study. SGA was defined as estimated fetal weight (EFW) and confirmed birth weight < 10 th centile according to local reference curves 15 . The reference cohort of fetuses with normal EFW and birth weight were sampled randomly from pregnancies at the same institution and paired with the SGA cases according to gestational age at fetal scan. The study protocol was approved by the Hospital Clínic Ethics Committee, and written parental consent was obtained for all study participants.
Baseline characteristics and pregnancy outcome
Maternal characteristics including age, height, weight, body mass index, smoking during pregnancy and parity were recorded. Gestational age at the scan was calculated based on the crown-rump length obtained at first-trimester screening 16 . Ultrasonographic examinations were performed using a Siemens Sonoline Antares machine (Siemens Medical Systems, Malvern, PA, USA) and included EFW and standard obstetric Doppler evaluation, comprising measurement of mean uterine artery (UtA) pulsatility index (PI), umbilical artery PI, fetal middle cerebral artery PI and ductus venosus PI as well as the cerebroplacental ratio (CPR), according to methodology published previously 17 -20 . Doppler parameters were normalized into Z-scores according to published reference values 17 -20 . EFW was calculated according to the method of Hadlock et al. 21 and EFW centile was calculated using local reference curves 15 . At delivery, pregnancy complications, prenatal glucocorticoid exposure, gestational age at birth, mode of delivery, birth weight, birth-weight centile and Apgar scores were recorded. Birth-weight centile was calculated using local reference curves 15 . If the infant was admitted to the neonatal intensive care unit, the length of stay in days was recorded. We calculated the estimated date of delivery (i.e. 40 weeks' gestation) based on the first-trimester crown-rump length and scheduled follow-up examinations at 6 months from this date (i.e. 6 months corrected age).
Fetal and infant echocardiographic assessment
Fetal echocardiography was performed initially to assess structural heart integrity using a Siemens Sonoline Antares machine (Siemens Medical Systems); cardiovascular evaluation was performed using a curved-array 2-6-MHz transducer, with the exception of tissue Doppler measurements, which required a phased-array 2-10-MHz transducer. Infant echocardiography, performed using a Vivid Q (GE Healthcare, Horten, Norway) ultrasound machine equipped with a with a 10S-RS phased-array 4.5-11.5-MHz transducer, included a complete two-dimensional M-mode and Doppler echocardiographic examination to verify structural heart integrity, with morphometric and functional data also being recorded.
A complete description of the prenatal and postnatal evaluations may be found in the Supplementary Methods section (Appendix S1); the following measurements were performed at both time points. Cardiac morphometry included left atrial area, ventricular sphericity index and interventricular septum thickness. Systolic function evaluation included heart rate, ejection fraction (EF), stroke volumes (SV), cardiac outputs (CO), mitral and tricuspid annular-plane systolic excursions (MAPSE and TAPSE, respectively) and systolic annular peak velocities (S ). Diastolic function evaluation included left isovolumetric relaxation time (IRT), ratio of early transvalvular filling peak velocity to late transvalvular filling peak velocity (E/A), E deceleration time, A duration time and early diastolic (E ) and late diastolic (A ) annular peak velocities.
Infant vascular evaluation
Vascular assessment included blood pressure measurement and aortic intima-media thickness (aIMT) measurement by ultrasound using Vivid Q (GE Healthcare) equipped with a 12 L-RS linear-array 6.0-13.0-MHz transducer. A controlled environment contributed to the achievement of all infant measurements. Systolic and diastolic blood pressure were obtained from the brachial artery using a validated ambulatory automated Omron 5 Series device. An appropriate cuff size, covering 40% of the arm circumference, was used to ensure accurate measurements 22 . Each infant's blood pressure was evaluated twice during quiescence and their average was determined. Measurement of aIMT in the upper abdomen involved obtaining longitudinal clips of the far wall of the proximal abdominal aorta in the upper Data are shown as mean ± SD or n (%). *Corrected age determined as time from estimated date of delivery according to first-trimester crown-rump length. EFW, estimated fetal weight; GA, gestational age; PI, pulsatility index; UtA, uterine artery.
abdomen with a 12 L-RS linear-array 6.0-13.0-MHz transducer 23, 24 . aIMT measurements were performed offline, according to a standardized protocol based on a trace method, with the assistance of a computerized program (GE EchoPAC PC 108.1.x, GE Healthcare) 25, 26 .
Finally, we performed a comparison of prenatal echocardiographic parameters within the SGA group, between different stages of severity 27 , subdividing this group into SGA defined by EFW between the 3 rd and 9 th centiles together with normal CPR and UtA Doppler, and late-IUGR, defined by EFW < 3 rd centile, or < 10 th centile together with CPR < 5 th centile and/or mean UtA-PI >95 th centile.
Statistical analysis
Data were analyzed using the IBM SPSS statistical package (IBM SPSS Statistics for Windows, Version 21.0., IBM Corp., Armonk, NY, USA). We compared study and control groups using Student's t-test, and present results as mean ± SD or n (%) as appropriate. P < 0.05 was considered statistically significant. Fetal parameters were adjusted by linear regression analysis for gender, gestational age at delivery and pre-eclampsia. Infant parameters were adjusted for gender, gestational age at delivery, prenatal glucocorticoid exposure, Cesarean delivery, admission to neonatal intensive care unit and body surface area.
RESULTS
In total, 95 fetuses diagnosed with SGA after 34 weeks' gestation were included initially; three cases were excluded prenatally upon diagnosis of chromosomal and/or structural abnormalities. Of the remaining 92 patients, 10 were lost to follow-up after delivery and two were excluded because of postnatal diagnosis of pulmonary stenosis, leaving a study cohort of 80 SGA cases, paired with 80 controls also recruited prenatally.
Baseline and perinatal characteristics
Baseline, perinatal and infant anthropometric characteristics of the control and SGA groups are shown in Table 1 . Maternal characteristics and gestational age at fetal scan were similar between the groups. As expected, prenatal Doppler parameters and most pregnancy outcomes were significantly worse in the SGA group: 21.4% of Data are shown as mean ± SD. *Fetal P-values adjusted by linear regression for gender, gestational age at delivery and pre-eclampsia. †Infant P-values adjusted by linear regression for gender, gestational age at delivery, prenatal glucocorticoid exposure, Cesarean delivery, admission to neonatal intensive care unit and body surface area. A, late transvalvular filling peak velocity; A , late diastolic annular peak velocity; E, early transvalvular filling peak velocity; E , early diastolic annular peak velocity; MAPSE, mitral annular plane systolic excursion; mths, months; S , systolic annular peak velocity; TAPSE, tricuspid annular plane systolic excursion; wks, gestational weeks.
the SGA group had abnormal UtA Doppler and 10.4% had abnormal umbilical artery Doppler; 9.1% showed brain vasodilation, with abnormal middle cerebral artery PI, and 28.6% had abnormal CPR (Table S1 ). Rate of pre-eclampsia was not different between the groups. Anthropometric data for the 6-month-old infants showed that those in the SGA group had significantly lower height, weight, body mass index and body surface area, compared with controls, with no significant difference in age at assessment or gender.
Fetal and postnatal echocardiography
Results of both fetal and infant echocardiography are shown in Table 2 and examples are given in Figure 1 . Cardiac morphometric findings were concordant between fetal and infant evaluations, showing larger atrial areas, decreased left sphericity index and thicker septal wall in the SGA group compared with controls. Global systolic function parameters, including heart rate, EF, left SV and left CO showed little or no difference between the groups at both points in time, while right SV was significantly different prenatally but this did not persist into infancy, and right CO was significantly higher prenatally but significantly lower in infancy. Longitudinal motion parameters MAPSE, TAPSE and S were all significantly decreased in the SGA group compared with controls, both pre-and postnatally. With respect to diastolic function parameters, IRT was increased in the SGA group, while tissue Doppler velocities E and A were significantly decreased, in fetuses and infants alike. E/A ratio was significantly increased in the SGA group compared with controls prenatally, but this did not persist into infancy. In contrast, both E deceleration time and A duration showed higher values in the SGA fetuses, compared with controls, with the difference becoming significant or more pronounced in infancy. The complete echocardiographic parameter evaluations for fetal and infant life can be found in Tables S2 and S3 .
Prenatal classification of growth-restriction severity and cardiac function
Results of the subanalysis comparing prenatal echocardiographic parameters within the SGA group are displayed in Table 3 . Twenty-nine fetuses were subclassified as SGA and 51 as late-IUGR, of which 22 (43%) had CPR < 5 th centile and 15 (29%) had UtA-PI > 95 th centile. Both SGA and late-IUGR presented changes in cardiac shape, with larger and more globular hearts, and signs of cardiac dysfunction; however, there were no significant differences in cardiac function between these subgroups.
Infant vascular assessment
Vascular data (Tables 4 and S4 ) showed significant differences between the SGA group and controls: systolic, diastolic and mean blood pressures as well as mean and maximum aIMT measurements were significantly increased in SGA infants, and these differences were maintained when adjusted by linear regression to perinatal confounding factors.
DISCUSSION
This study confirms the presence of cardiovascular remodeling and dysfunction in SGA, regardless of Doppler parameters, and demonstrates that a pattern of change is already present prenatally and remains essentially the same at 6 months of age. Our findings support the suggestion that primary cardiovascular remodeling starts in fetal life and is a main determinant of postnatal cardiac and vascular changes observed in affected children, showing that cardiovascular remodeling can be evidenced by functional echocardiography in utero and early infancy.
To our knowledge, this study is the first to perform an extensive functional echocardiographic investigation both pre-and postnatally in the same SGA subjects. Our data support previous studies demonstrating cardiac and vascular remodeling in children who had been growth-restricted prenatally, characterized by more globular hearts, maintained EF and CO with subclinical systolic dysfunction and subclinical diastolic dysfunction, along with increased blood pressure and aIMT 6, 7, 23, 24, 28 . Our study also concurs with previous studies that have reported some of these findings prenatally, including those reporting longitudinal dysfunction in IUGR fetuses 4, 5, 9, 28 or diastolic dysfunction evidenced by prolonged IRT 28, 29 .
We found that fetal CO demonstrated right-sided dominance, with higher values in SGA fetuses, in line with previous data demonstrating a shift towards higher volume load in the right ventricle, augmented during the last weeks of pregnancy and in the presence of IUGR 30 . We also observed changes in CO, from prenatal to postnatal circulation, consistent with previous reports that suggest a change in right-to-left ventricular CO ratio 31 , demonstrating left ventricular dominance in infancy, as expected. We observed that most of the aforementioned parameters presented significant differences between Table 3 Fetal echocardiographic evaluation at different stages of severity* in 80 small-for-gestational-age (SGA) fetuses
Late-IUGR (n = 51) P 27 . A , late diastolic annular peak velocity; E , early diastolic annular peak velocity; IUGR, intrauterine growth restriction; MAPSE, mitral annular plane systolic excursion; S , systolic annular peak velocity; TAPSE, tricuspid annular plane systolic excursion. Data are shown as mean ± SD. *P-values adjusted by linear regression for gender, gestational age at delivery, prenatal glucocorticoid exposure, Cesarean delivery, admission to neonatal intensive care unit and body surface area. aIMT, aortic intima-media thickness.
groups at both evaluations, supporting the existence of primary fetal cardiovascular programming which persists into infancy. In this study we also found cardiac morphometric changes not previously reported in fetuses with SGA 32, 33 . A more globular shape, dilated atria and thicker myocardial walls have been associated with pressure changes and volume overload to the fetal heart, due to the chronic state of hypoxia and elevated placental resistance present in IUGR 34, 35 . Pressure changes may lead to hypertrophy of the ventricular walls and changes in the local radius of curvature of the heart (creating a more spherical cavity) in order to compensate 36 . Previous studies have also demonstrated that children, adolescents and adults who were growth-restricted prenatally have higher blood pressures and markers for cardiovascular risk, such as increased carotid and aIMT 24 or changes in vessel diameter and heart rate 6, 12, 37 . We observed a significant difference in blood pressure and aIMT amongst our study groups in infancy, thus demonstrating that these changes can be characterized at an early stage in life. Some studies in animal models have found dilated-like cardiomyopathy in severe early IUGR, with lower ventricular mass and thinner myocardial walls 38, 39 ; this difference may be explained by the variability in timing of onset (early or late in gestation) and severity of the placental disease among the studies and different animal models. The majority of our population had near-term (late) IUGR, which may not be comparable to the situation in very preterm (early) IUGR; the latter subjects the fetus to extreme hypoxia early in gestation. Furthermore, our data agree with those of other studies that suggest the presence of subtle cardiac dysfunction in some SGA fetuses, which in fact have late-onset IUGR, regardless of the presence of Doppler abnormalities that are predictors of poorer perinatal outcome 40 . This reinforces the concept that these parameters do not discriminate fetal cardiovascular programming, and that all SGA infants are, potentially, at risk for cardiovascular disease and may benefit from postnatal surveillance.
Among the strengths of our study is the longitudinal work-up from fetal life to infancy, which allowed prospective evaluation of structural and functional echocardiographic parameters. Results were adjusted by all parameters considered relevant or potential perinatal confounders. Examination at 6 months of age was chosen as a reasonable point in time to avoid the effects of neonatal cardiovascular transition to postnatal life, although we recognize that blood pressure measurement at 6 months of age is challenging and may be highly variable, in spite of strict protocols 22 . We also acknowledge that using different equipment pre-and postnatally might lead to differences in absolute values of measurements 41 . Furthermore, CO is a highly variable parameter with limitations for its acquisition in fetal and postnatal life, although low coefficients of variation and good intraclass correlation have been reported, despite the lack of concurrent electrical timing of events in the fetus 30, 42 . These data provide strong evidence to support that, regardless of the logical existence of postnatal environmental modulators, primary cardiovascular remodeling occurring in utero is a main determinant of cardiovascular dysfunction in children who were growth-restricted prenatally. We also acknowledge that, although this study provides evidence of cardiac remodeling at 6 months of age, it remains to be determined whether there is a direct association with cardiovascular outcome and whether these findings will persist in the long term; further follow-up of this cohort is required.
Overall, our study provides more evidence supporting the suggestion that fetal primary cardiovascular remodeling exists in SGA and that this group should be considered at risk for cardiovascular disease later in life. The diagnosis of SGA/IUGR is established in about 5-10% of pregnancies; thus, the findings of this study would affect thousands of children per year. Hypertension in the child has been associated with substantial long-term health risks 22 , and aIMT measurement allows detection of increased cardiovascular risk, as an indicator of arterial remodeling in children 23, 24, 43 . Our study supports earlier screening in this population so that they may benefit from early interventions, such as prevention of exposure to other risk factors, surveillance of catch-up growth and promotion of breastfeeding, exercise and physical activity 22 . Recent studies have also demonstrated the benefit of a high intake of dietary long-chain ω-3 fatty acids in reducing blood pressure, thus preventing progression of subclinical atherosclerosis in children with low birth weight 43 , and the benefit of a Mediterranean diet in reduction of cardiovascular risk 44, 45 , all interventions which could be applied easily to this population to reduce the probability of cardiovascular disease later in life.
In conclusion, primary cardiovascular changes are already present in the growth-restricted fetus and persist at 6 months of age. These data support prenatal cardiovascular remodeling as a mechanistic pathway of increased risk later in life in cases of SGA, regardless of Doppler abnormalities.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article: Appendix S1 Supplementary methods 
